eprintid: 106
rev_number: 10
eprint_status: archive
userid: 30
dir: disk0/00/00/01/06
datestamp: 2017-03-21 10:02:13
lastmod: 2017-03-21 10:02:13
status_changed: 2017-03-21 10:02:13
type: thesis
metadata_visibility: show
creators_name: Carroll, Glenn
title: Supporting Irish Start-Ups in the Life Science Sector: An assessment of how the support structures provided by Enterprise Ireland are utilised by Irish Life Science Startups
ispublished: submitted
subjects: HB
divisions: MBAIB
full_text_status: public
keywords: Life Science Sector, Start-ups, Enterprise Ireland,
note: Dissertation Supervisor: Dr. John Cashell
abstract: This study evaluates the supports that Enterprise Ireland is currently providing to startup companies in the Irish Life Science sector by exploring how seven different Irish start-ups within the sector have utilised  the support system. This study found that the current Life Science support network within Ireland was found to be effective at funnelling potential start-ups into the Enterprise Ireland support system and it was also found companies with reasonable business plans are receiving the required level of funding and support to scope out their business plans. In all seven companies studied, Enterprise Ireland funding and support was sufficient for the business to navigate the difficult first year following formation / spin-out.  At approximately the one year mark the way in which each company interacted with Enterprise Ireland diverged significantly. The companies who were successful in securing revenue from external investors grew quickly and generated a significant level of employment, whereas the companies that could not secure this funding stalled in their development. In two cases there was difference of opinion between Enterprise Ireland and the founders of the companies with respect to the future development of the business, this had a negative impact on how the companies engaged with the support processes. Overall it was concluded that the current support system provided by Enterprise Ireland is performing well when it comes to the identification of viable candidate companies and is offering the supports needed in the critical early stages of business development.  Two key areas where the current offerings require improvement were identified; firstly, more assistance is needed for companies who are having difficulty securing external sources of funding as this was a significant road block to business development. Secondly, the depth of Enterprise Ireland business mentors within the Life Science sector requires development as a number of companies could not gain access to the required level expertise needed to develop their business plans.
date: 2015
date_type: submitted
institution: Griffith College
department: Graduate Business School
thesis_type: masters
referencetext: APC, 2015. APC: Official Company Website. Available at: http://www.approcess.com/

Bioplastech, 2015. Bioplastech: Official Company Website. Available at: http://www.bioplastech.eu/

Breedlove, P., 2014. Overcoming the odds: How to incubate fledging bioscience companies. Nanotechnology Law & Business, 101, pp.101–106. 

Breznitz, S.M., 2013. Cluster Sustainability: The Israeli Life Sciences Industry. Economic Development Quarterly, 27(1), pp.29–39. 

Brightwater, 2015. Brightwater Salary Survey 2015. Available at: http://www.brightwater.ie/docs/default-source/salary-surveys/salary-survey2015.pdf?sfvrsn=2. 
Burke, El., 2013. Pfizer seeking 150 redundancies in Newbridge plant. SIliconRepublic. Available at: http://www.siliconrepublic.com/business/item/35058-pfizer-seeking-150/. 
BusinessEtc, 2013. 570 job losses at pharmaceutical company in Dublin. Available at: http://businessetc.thejournal.ie/job-losses-msd-dublin-1196799-Nov2013/. 
Calvert, J. & Senker, J., 2004. Biotechnology innovation systems in two small countries: a comparison of Portugal and Ireland. Science & Public Policy (SPP), 31(5), pp.359–370. 
Connolly, P., 2012. HPSU startup of the day: TriMod Therapeutics. The Daily Business Post. Available at: http://www.businesspost.ie/#!story/Home/News/HPSU+startup+of+the+day%3A+Tri Mod+Therapeutics/id/19410615-5218-4f8d-774f-9baf50201850. 
Cooke, P., 2002. Biotechnology Clusters as Regional, Sectoral Innovation Systems. International Regional Science Review, 25(1), pp.8–37. 
CSCB, 2008. Dr Kevin O’Connor wins NovaUCD Start-up award. Available at: http://www.ucd.ie/cscb/main_pages/news/news211108.html. 
Deval L, P., 2008. FY2010 House 1 Budget Recommendation: Policy Brief. Available at: http://www.mass.gov/bb/h1/fy10h1/prnt10/exec10/pbudbrief23.htm. 
Enterprise Ireland, 2004. Enterprise Ireland Annual Report and Accounts 2004: Opsona Therapeutics Ltd. Available at: http://www.enterpriseireland.com/annualreport2004/opsona.html. 
Enterprise Ireland, 2015. Enterprise Ireland: Research Commercialisation. Available at: http://www.enterprise-ireland.com/en/Researchers/Research-CommercialisationSupports/. 
Enterprize Ireland, 2015. Enterprise Ireland:Technology Transfer Supports. Available at: http://www.enterprise-ireland.com/en/Researchers/Technology-Transfer-SupportSystem/. 
  
68 
 
Enzing, C., van der Giessen, A. & Kern, S., 2004. Commercialisation of biotechnology: do dedicated public policies matter? Science and Public Policy, 31(5), pp.371–383. 
ERM, 2014. What is your paradigm. Available at: http://www.erm.ecs.soton.ac.uk/theme2/what_is_your_paradigm.html. 
Hine, D. & Kapeleris, J., 2006. Innovation and Entrepreneurship in Biotechnology, an International Perspective, Concepts, Theories and Cases. Cheltenham, UK: Edward Elgar. 
Hunt, V., Manson, N. & Morgan, P., 2011. A wake-up call for Big Pharma, Lower profit margins suggest a need for new business models. Available at: http://www.mckinsey.com/insights/health_systems_and_services/a_wakeup_call_for_big_pharma. 
Kennedy, J., 2013. 280 pharmaceutical jobs to go at MSD plant in Wicklow. SIliconRepublic. Available at: http://www.siliconrepublic.com/business/item/31782-280pharmaceutical-jobs-to/. 
Mac Coille, C. & Gorman, J., 2012. Ireland and the Pharma Patent Cliff. Available at: http://www.davy.ie/content/pubarticles/patentcliff20121128.pdf. 
McAdam, M. & Marlow, S., 2007. Building Futures or Stealing Secrtes?: Entrepreneurial Cooperation and COnflict within Business Incubators. International Small Business Journal, 25(4), pp.361 – 382. 
McAleer, M., 2014. Taoiseach lauds entrepreneurs at “Irish Times” Innovation Awards. Irish Times. Available at: http://www.irishtimes.com/business/taoiseach-laudsentrepreneurs-at-irish-times-innovation-awards-1.1759304. 
McSorley, A., 2015. 18 job losses at Waterford pharmaceutical site. Available at: http://utv.ie/News/2015/01/09/18-job-losses-at-Waterford-pharmaceutical-site25941. 
Medical Marketing, 2003. R&D Costs are on the rise. Available at: http://www.highbeam.com/doc/1G1-102908512.html. 
Moran, M., 2013. Irish pharmachem industry fights to maintain its global position. Available at: http://www.engineersjournal.ie/irish-pharmachem-industry-fights-to-maintain-itsglobal-position/. 
Mullin, R., 2014. Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B. Scientific American. Available at: http://www.scientificamerican.com/article/cost-to-developnew-pharmaceutical-drug-now-exceeds-2-5b/. 
Nosella, A. & Grimaldi, R., 2009. University-level mechanisms supporting the creation of new companies : an analysis of Italian academic spin-iffs. Technology Analysis & Strategic Management, 21(6), pp.679 – 698. 
NovaUCD, 2011. APC, A New Pharmaceutical Research and Technologies Company, Wins the NovaUCD 2011 Start-Up Award. Available at: http://www.ucd.ie/nova/mediacentre/2011pressreleases/novanewstitle,109725,en.ht ml. 
  
69 
 
Oncomark, 2015. Oncomark: Official Company Website. Available at: http://www.oncomark.com. 
O’Neill, B., 2011. Enterprise Ireland: Helping Irish companies achieve global success. Available at: http://www.dkit.ie/system/files/DKIT%20Pharma%20Presentationbrian%20o%20neill.ppt.pdf. 
Opsona, 2015. Opsona Therapeutics: Official COmpany Website. Available at: http://www.opsona.com. 
O’Riordan, S., 2012. More job losses likely at pharma giant Pfizer. Irish Examiner. Available at: http://www.irishexaminer.com/ireland/more-job-losses-likely-at-pharma-giant-pfizer196477.html. 
Oxymem, 2015. Qxymem: History. Available at: http://www.oxymem.com/history/. 
Peinin, J. & Wolff, S., 2010. Start-up Creation in Biotechnology: Lessons from the case of four new ventures in the upper Rhine Biovalley. Internation Journal of Innovation Management, 14(2), pp.253–283. 
PharmaChemicalIreland, 2014. Pharmaceutical Industry Profile in Ireland. Available at: http://www.pharmachemicalireland.ie/Sectors/PCI/PCI.nsf/vPages/About_us~industry -profile?OpenDocument. 
PhRMA, 2013. The Economic Impact of the U.S. Biopharmaceutical Industry. Available at: http://www.phrma.org/sites/default/files/pdf/The-Economic-Impact-of-the-USBiopharmaceutical-Industry.pdf. 
Porter, M., 2000. Location, competition and economic development: local clusters in a global economy. Economic Development Quarterly, 14, pp.15–34. 
Reiss, T., Hinze, S. & Lacasa, I.D., 2004. Performance of European Member States in biotechnology. Science & Public Policy (SPP), 31(5), pp.344–358. 
Robinson, C., 2002. Real World Research. A Resource for Social Scientists and PractitionerResearchers, (Second Edition). Malden: Blackwell. 
Rockoff, J.D., 2009. Merck to Buy Rival for $41 Billion. Wall Street Journal. Available at: http://www.wsj.com/articles/SB123659326420569463. 
RTE, 2014. 160 jobs to go at Bristol-Myers Squibb. Available at: http://www.rte.ie/news/2014/0306/600602-bristol-myers-squibb/. 
Ryan, V., 2013. Pharma patent cliff continues to eat into country’s export performance. The Irish Examiner. Available at: http://www.irishexaminer.com/business/pharma-patentcliff-continues-to-eat-into-countrys-export-performance-246367.html [Accessed November 5, 2013]. 
Salvador, E. & Rolfo, S., 2001. Are Incubators and Science parks effective for research spinoffs? Evidance from Italy. Science and Public Policy, 38(3), pp.170–184. 
SFI Ireland, 2013. SFI Mission Statement. Available at: http://www.sfi.ie/about/vision-missionstatement.html. 
  

Siggins, L., 2014. Beckman Coulter to close Galway plant with 140 job losses. Irish Times. Available at: http://www.irishtimes.com/business/health-pharma/beckman-coulterto-close-galway-plant-with-140-job-losses-1.1949341. 
Smilor, R.., 1997. Entrepreneurship: Reflections on a Subcersive Activity. Journl of Business Venturing, 12(3), pp.314 – 346. 
Smilor, R.. & Gill, M.., 1986. The New Business Incubator: Linking Talent, Technology, Capital and Know-How, 
Solvotrin, 2015. Solvotrin Therapeutics: Official Company Website. Available at: http://www.solvotrin.com/. 
Staton, T., 2014. Pfizer’s post-megamerger cost-cutting record? 51,500 jobs in 7 years. Fierce Pharma. Available at: http://www.fiercepharma.com/story/pfizers-post-megamergercost-cutting-record-51500-jobs-7-years/2014-04-29. 
Thomas, K., 2013. Merck Plans to Lay Off Another 8,500 Workers. New York Times. Available at: http://www.nytimes.com/2013/10/02/business/merck-plans-to-lay-off-8500workers.html?_r=1. 
Totterman, H. & Sten, J., 2005. Start-ups: Business Incubation and Social Capital. International Small Business Journal, 23(5), pp.487 – 511. 
UCD, 2014. UCD spin-out, OxyMem announced overall winner at the 2014 Irish Times InterTradeIreland Innovation Awards. Available at: http://www.ucd.ie/news/2014/04APR14/100414-UCD-spin-out-OxyMem-announcedoverall-winner-at-the-2014-Irish-Times-InterTradeIreland-Innovation-Awards.html. 
Uctu, R. & Jafta, R.C.., 2013. Bio-entrepreneurship as a bridge between science and business in a regional cluster: South Africa’s first attempts. Science & Public Policy (SPP), 41, pp.219–233. 
UniversityWatchdog, 2009. The Capitulation of Science Foundation Ireland. Available at: http://universitywatchdog.wordpress.com/category/science-foundation-ireland/. 
Urbig, D. et al., 2013. Investor Reactions to New Product Development Failures The Moderating Role of Product Development Stage. Journal of Management, 39(4), pp.985–1015.
citation:   Carroll, Glenn  (2015) Supporting Irish Start-Ups in the Life Science Sector: An assessment of how the support structures provided by Enterprise Ireland are utilised by Irish Life Science Startups.  Masters thesis, Griffith College.   
document_url: http://go.griffith.ie/106/1/MBAIB_2015_Glenn_Carroll.pdf
document_url: http://go.griffith.ie/106/2/bibliography.txt